Related Experiment Video
Updated: May 18, 2026
06:02
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
[Hypertrophic cardiomyopathy. Clinical and morphological comparisons]
Arkhiv Patologii
|September 25, 2012
Summary
This study compares myocardial morphology in children and adults with obstructive hypertrophic cardiomyopathy. Key risk factors for sudden cardiac death in adults include younger age and specific ventricular septum changes.
Area of Science:
- Cardiology
- Pathology
- Pediatrics
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart disease characterized by left ventricular hypertrophy.
- Obstructive HCM presents with significant asymmetric septal hypertrophy, impacting cardiac function.
- Understanding morphological differences between pediatric and adult HCM is crucial for risk stratification.
Purpose of the Study:
- To comparatively analyze myocardial morphology in pediatric and adult patients with obstructive hypertrophic cardiomyopathy.
- To identify specific morphological features associated with sudden cardiac death risk in adults with obstructive HCM.
Main Methods:
- Comparative analysis of myocardial tissue samples from pediatric and adult obstructive HCM patients.
- Histopathological examination focusing on ventricular septum (VS) morphology, including stromal changes.
- Correlation of morphological findings with clinical data, including sudden death events.
Main Results:
- Significant asymmetric left ventricular hypertrophy, particularly of the ventricular septum (VS), was observed in all analyzed cases.
- In adults with obstructive HCM, younger age (<45 years) was associated with increased sudden death risk.
- Stromal enlargement in the right VS, near the endocardium, emerged as a critical risk indicator in adult obstructive HCM.
Conclusions:
- Myocardial morphology in obstructive hypertrophic cardiomyopathy differs between children and adults.
- Specific VS morphological characteristics, such as stromal enlargement, are vital for assessing sudden cardiac death risk in adults.
- These findings aid in tailoring management strategies for patients with obstructive HCM.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...